Results 1 to 10 of about 25,067 (232)
Frontiers in Pharmacology, 2023 The ongoing Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has imposed a huge threat to public health across the world.
Yuanyuan Yu +6 more
doaj +1 more source
Clinical Case Reports, 2023 Acute severe bronchial asthma is a chronic inflammatory disease characterized by hyperresponsiveness of the airways leading to bronchoconstriction. We present a case of refractory life‐threatening bronchial asthma that was managed with sevoflurane gas ...
Satheesh Munusamy +3 more
doaj +1 more source
Pharmacotherapeutic strategy for COPD patients: focus on dual bronchodilators
Медицинский совет, 2021 For two decades, the GOLD Initiative has consistently identified the use of bronchodilators as a priority in the pharmacotherapeutic strategy for COPD.
A. I. Sinopalnikov
doaj +1 more source
Pharmaceuticals, 2023 This work aims to investigate bronchodilator delivery with the use of different vaping drug delivery systems (VDDS) by determining the dose equivalence delivered in relation to different references: a clinical jet nebulizer, a pMDI (pressurized metered ...
Mariam Chaoui +5 more
doaj +1 more source
The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
Sinusitis, 2022 Chronic obstructive pulmonary disease (COPD) is a global public health burden that stands out as a leading cause of mortality around the world, especially in less developed countries.
Ricardo G. Figueiredo +2 more
doaj +1 more source
Pharmaceuticals, 2022 The co-administration of a long-acting β2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA), has been shown to be beneficial in the management of non-communicable chronic respiratory diseases, such as asthma and chronic obstructive pulmonary
Elena Menchi +5 more
doaj +1 more source
Recent trends in management of bronchial asthma
Zagazig Journal of Pharmaceutical Sciences, 2021 Bronchial Asthma is the most common chronic inflammatory disease of lungs. The prevalence of asthma is increasing worldwide, and the disease possesses a substantial global health and economic burden.
Ashraf elsayed Sileem +3 more
doaj +1 more source
South African Family Practice, 2020 International and national guidelines on chronic obstructive pulmonary disease (COPD) emphasise bronchodilators as first-line therapy. However, in considering them the ‘foundation’ of treatment, attention has shifted from the fact that COPD is ...
Elvis M. Irusen, Thandeka Malange
doaj +1 more source
Determination of the effectiveness of short-term nebulizer therapy in bronchiectasis
Infusion & Chemotherapy, 2022 BACKGROUND. While the incidence of bronchiectasis is increasing every year, the treatment of this category of patients today is a real challenge for practical medicine, as the only existing guideline contain only low and medium quality data. OBJECTIVE.
K.Yu. Gashynova +2 more
doaj +1 more source
Journal of the Formosan Medical Association, 2011 Microsomal epoxide hydrolase (EPHX) is an important enzyme that metabolizes harmful reactive epoxides from smoking. Genetic variations of this enzyme are thought to increase the risk of developing chronic obstructive pulmonary disease (COPD).
Chiung-Zuei Chen +5 more
doaj +1 more source